comparemela.com

Latest Breaking News On - Ximenaa levander - Page 1 : comparemela.com

Despite soaring overdose rates, Americans face barriers to treatment

Despite soaring overdose rates, Americans face barriers to treatment
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Study: Pharmacies can be a significant access barrier to key medication for addiction

Study: Pharmacies can be a significant access barrier to key medication for addiction One in five pharmacies refuse to dispense a key medication to treat addiction, according to new research. The study, published in the journal Drug and Alcohol Dependence, was conducted by researchers at Oregon Health & Science University and the Oregon State University College of Pharmacy. Researchers called hundreds of pharmacies around the country to ask whether they would dispense Suboxone, also known as buprenorphine. Buprenorphine is a vital, lifesaving medication for people with opioid use disorder, but improving access has been a problem for a variety of reasons. Although anecdotes and smaller studies have suggested problems, our study is the first to systematically characterize this barrier.

One in five pharmacies blocks access to key medication to treat addiction

 E-Mail One in five pharmacies refuse to dispense a key medication to treat addiction, according to new research. The study, published in the journal Drug and Alcohol Dependence, was conducted by researchers at Oregon Health & Science University and the Oregon State University College of Pharmacy. Researchers called hundreds of pharmacies around the country to ask whether they would dispense Suboxone, also known as buprenorphine. Buprenorphine is a vital, lifesaving medication for people with opioid use disorder, but improving access has been a problem for a variety of reasons, said senior author Daniel Hartung, Pharm.D., M.P.H., professor in the College of Pharmacy. Although anecdotes and smaller studies have suggested problems, our study is the first to systematically characterize this barrier.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.